Navigation Links
World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)

New evidence from large-scale studies points to a relationship between erectile dysfunction and prostate enlargement. Because of this, J. Francois Eid, M.D. has decided to expand his practice to increase the treatment of BPH in men. The focus of Dr. Eid's practice, Advanced Urological Care, has primarily been erectile dysfunction (ED). Dr. Eid will continue with ED treatments while building his BPH caseload.

New York, New York (PRWEB) November 21, 2008 -- Dr. J. Francois Eid has performed more internal penile implant surgeries than anyone in the world and has built a reputation for excellence in the treatment of erectile dysfunction (ED). New evidence from large-scale epidemiological studies supports the relationship between erectile dysfunction and lower urinary tract symptoms caused by benign prostate enlargement. Furthermore, studies show that the chemical nitric oxide (NO) plays an important role in normal erectile function and in the function of the prostate. Finally, animal studies reveal that obstruction of the bladder by the prostate causes erectile dysfunction. For these reasons, Dr. Eid is now expanding his practice to treat more patients with benign prostate hyperplasia (BPH). Though he has treated many men with BPH in the past, Dr. Eid would like to make BPH a central area of focus, along with erectile dysfunction.

Little known is the fact that BPH affects 40 percent of men in their 50s, 60 percent of men in their 60s and more than 80 percent of men in their 80s. Many men who experience the symptoms of BPH, like an increased need to urinate or a weak urinary stream, attribute such symptoms to aging and believe such bothersome annoyances are something they simply have to live with. In reality, there are numerous treatments for BPH and Dr. Eid is highly skilled at diagnosing and treating the disease.

Benign prostate hyperplasia is caused by an enlarged prostate gland, which continues to grow throughout a man's lifetime. If the growth exceeds a certain limit, the enlarged prostate presses on the bladder neck and urethra, causing problems with voiding and storage of urine. If BPH is left untreated, permanent urinary problems may occur that seriously impact quality of life. Dr. Eid is driven to increase his BPH caseload because he believes the disease is under-diagnosed and can be treated easily with lasting solutions.

The following are typical symptoms of BPH:

-   Frequent need to urinate
-   Urgent need to urinate
-   Intermittent urine flow
-   Incomplete emptying of the bladder
-   Dribbling or leaking of urine
-   Painful urination
-   Blood in the urine
-   Failure to empty bladder completely
-   Need to urinate during the night
-   Bladder pain
-   Weak urine stream

Once Dr. Eid determines a patient has BPH, he asks them to answer a series of questions that determine the severity of the prostate enlargement and consequent symptoms. These questions are the basis of a test called the BPH Symptom Score Index, or the American Urological Association Score. If symptoms are mild, watchful waiting is usually recommended. If symptoms are moderate to severe, Dr. Eid recommends medications or surgery with minimally invasive procedures.

Alpha blockers, which include Flomax, Cardura, Hytrin and Uroxatral are the most common way to treat BPH. They work by relaxing the prostate gland's smooth muscle cells so that the urinary obstruction is reduced. The disadvantages of oral treatments are that medications may become ineffective over time and may have bothersome side effects. Also, the need to take pills is cumbersome for some men.

Minimally invasive, non-surgical treatments for BPH include thermotherapy, or transurethral microwave therapy (TUMT). This office treatment, which is a breakthrough in the treatment of BPH, uses heat to reduce excess tissue pressing on the urethra from the enlarged prostate. No anesthesia is needed and thermotherapy is performed in less than an hour. Over 70% of men experience rapid relief of symptoms and are relieved of the burden of taking medication.

If a patient's BPH symptoms are severe and first line treatments have failed, Dr. Eid will recommend laser therapy. GreenLight laser treatment for BPH is becoming increasingly common and is preferred over a surgical procedure called a transurethral resection of the prostate (TURP) because of the reduced blood loss, avoidance of a catheter and quicker discharge and recovery time. Dr. Eid is an exceptionally qualified urological surgeon for this procedure and is widely recognized for advancing his field. Only on very rare occasions will Dr. Eid suggest a prostatectomy (complete removal of the prostate gland) or a transurethral resection of the prostate.

First and foremost, Dr. Eid wants men to understand that BPH is eminently treatable and is associated with and can cause ED. He is driven to help men with BPH find the most appropriate cure and live uncompromised lives.

About J. Francois Eid, M.D, and

Dr. Eid is the director and founder of Advanced Urological Care in New York City. He is also a Clinical Associate Professor of Urology at Cornell University. Dr. Eid is one of the foremost specialists in urological prosthetic reconstruction and performs over 300 internal penile implant surgeries per year. Dr. Eid leads workshops on penile prosthesis surgeries worldwide. More information about BPH and Dr. Eid can be found at his website:

# # #

Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. World-Renowned Physicians Converge on Methodist Dallas Medical Center for Largest Live Demonstration of Its Kind in Texas
2. World-Renowned Scientists to Lead Immunology Course
3. World-renowned bioengineers to record history of medical inventions
4. World-Renowned Therapist Joins The Center for Children and Families In Its Work With the Nations Poorest Families
5. Lifeclinic International Has Named John T. Kelly, M.D., Ph.D. Chief Medical Officer
6. Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss No Diet, No Stuff Method. Hates Diets, Loves to Have People Help Themselves
7. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
8. Whos Who Weight Specialist Martin Schiff, M.D., 86, Devoting Rest of Life to Spreading Truth About Diets, Wont Accept Compensation From Anyone, Sending Complete Guide Free to All
9. Mary Anne McCaffree, M.D., Elected to AMA Board of Trustees
10. Andrew W. Gurman, M.D., Re-Elected to Vice Speaker, AMA House of Delegates
11. William A. Hazel, Jr., M.D., Re-Elected to AMA Board of Trustees
Post Your Comments:
Related Image:
World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)
(Date:11/25/2015)... ... November 25, 2015 , ... In honor of Pulmonary Hypertension ... and groups responsible for advancing care for pulmonary hypertension (PH) patients and helping ... public, will receive special recognition throughout 2016 as part of PHA’s 25th anniversary ...
(Date:11/25/2015)... ... 25, 2015 , ... Bcureful—a non-profit organization devoted to advancing ... public awareness of the disorder while helping to bring expert medical care and ... bolster progress at the Tuberous Sclerosis Complex Center at Ann & Robert H. ...
(Date:11/24/2015)... ... 2015 , ... Eric C. Seidel, DMD and Stephanie DeFilippo, ... revolutionary BIOLASE WaterLase iPlus 2.0™ system. This advanced laser technology uses light energy ... dentist in Gettysburg, PA . From routine visits to cosmetic treatments, laser dentistry ...
(Date:11/24/2015)... CA (PRWEB) , ... November 24, 2015 , ... ... sizes, has launched their Black Friday sale a week early, offering 40% off ... to transform the intimate apparel industry through both mobile fit technology and the ...
(Date:11/24/2015)... ... ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, Dec. ... has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls under ... the device regulations. , Come up short in an inspection and the FDA can ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... Investors"), pursuant to which BioLight and the New Investors ... Ltd. subsidiary ("IOPtima") via a private placement. The financing ... its innovative IOPtimate™ system used in the treatment of ... pathway process for the IOPtimate™ system with the U.S. ...
(Date:11/25/2015)... 2015 Developmental, commercial, and regulatory/legal ... profitability of pharmaceutical products, says GBI Research ... regulatory/legal strategies all play a key role in boosting ... . --> Developmental, commercial, ... in boosting the profitability of pharmaceutical products, says ...
(Date:11/25/2015)... Research and Markets ( ) has ... Global Forecast to 2020" report to their offering. ... 37.21% of the total market share in 2014. The ... is projected to growth at the highest CAGR between ... to the fast growing water, industrial gas treatment, pharmaceutical, ...
Breaking Medicine Technology: